Enhancing Innovations in Emerging Technologies for Advanced Manufacturing of Complex Biologic Products (R01)

Archived

Food and Drug Administration

Description

CBER seeks to support the application of novel technologies for advanced manufacturing of complex biologic products, and innovative analytical approaches to improve product manufacturing and quality through active research.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses

Contact

Bryce Jones <br/>Grants Management Specialist <br/>Phone 240-402-2111
bryce.jones@fda.hhs.gov

Key dates & funding
  • PostedApr 23, 2018
  • ClosesJun 25, 2018
  • Award ceiling$600,000
  • Program funding$3,000,000
  • Expected awards5
  • CFDA93.103

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro